On Some Statistical Considerations in Testing for Multiple Endpoints in Clinical Trials Mohammad Huque, Ph.D. Division of Biometrics III/Office of Biostatistics/OPaSS/CDER/FDA ASA Biopharm Section FDA/Industry Workshop, September.

Download Report

Transcript On Some Statistical Considerations in Testing for Multiple Endpoints in Clinical Trials Mohammad Huque, Ph.D. Division of Biometrics III/Office of Biostatistics/OPaSS/CDER/FDA ASA Biopharm Section FDA/Industry Workshop, September.